aveanna healthcare holdings inc - AVAH
AVAH
Close Chg Chg %
6.63 -0.02 -0.30%
Pre-Market
6.61
-0.02 (0.30%)
Volume: 920.32K
Last Updated:
Apr 9, 2026, 4:00 PM EDT
Company Overview: aveanna healthcare holdings inc - AVAH
AVAH Key Data
| Open $6.58 | Day Range 6.44 - 6.64 |
| 52 Week Range 3.73 - 10.32 | Market Cap $1.44B |
| Shares Outstanding 217.51M | Public Float 73.18M |
| Beta 2.09 | Rev. Per Employee N/A |
| P/E Ratio 6.33 | EPS $1.08 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.28M |
AVAH Performance
| 1 Week | 3.61% | ||
| 1 Month | -5.03% | ||
| 3 Months | -23.05% | ||
| 1 Year | 47.22% | ||
| 5 Years | N/A |
AVAH Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
12
Full Ratings ➔
About aveanna healthcare holdings inc - AVAH
Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. It operates through the following business segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing services. The HHH segment provides home health, hospice, and program services to predominately elderly populations. The MS segment offers supplies to patients requiring enteral nutrition services or respiratory care. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA.
AVAH At a Glance
Aveanna Healthcare Holdings, Inc.
400 Interstate North Parkway SE
Atlanta, Georgia 30339
| Phone | 1-770-441-1580 | Revenue | 2.43B | |
| Industry | Medical/Nursing Services | Net Income | 225.03M | |
| Sector | Health Services | 2025 Sales Growth | 20.187% | |
| Fiscal Year-end | 12 / 2026 | Employees | 35,500 | |
| View SEC Filings |
AVAH Valuation
| P/E Current | 6.334 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 7.719 |
| Price to Sales Ratio | 0.714 |
| Price to Book Ratio | 8.767 |
| Price to Cash Flow Ratio | 14.21 |
| Enterprise Value to EBITDA | 10.339 |
| Enterprise Value to Sales | 1.257 |
| Total Debt to Enterprise Value | 0.495 |
AVAH Efficiency
| Revenue/Employee | 68,540.817 |
| Income Per Employee | 6,338.986 |
| Receivables Turnover | 7.697 |
| Total Asset Turnover | 1.313 |
AVAH Liquidity
| Current Ratio | 1.32 |
| Quick Ratio | 1.32 |
| Cash Ratio | 0.455 |
AVAH Profitability
| Gross Margin | 32.876 |
| Operating Margin | 10.997 |
| Pretax Margin | 4.395 |
| Net Margin | 9.248 |
| Return on Assets | 12.143 |
| Return on Equity | 634.703 |
| Return on Total Capital | 13.168 |
| Return on Invested Capital | 16.741 |
AVAH Capital Structure
| Total Debt to Total Equity | 778.824 |
| Total Debt to Total Capital | 88.621 |
| Total Debt to Total Assets | 74.764 |
| Long-Term Debt to Equity | 675.747 |
| Long-Term Debt to Total Capital | 76.892 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Aveanna Healthcare Holdings Inc - AVAH
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.79B | 1.90B | 2.02B | 2.43B | |
Sales Growth
| +6.50% | +6.02% | +6.82% | +20.19% | |
Cost of Goods Sold (COGS) incl D&A
| 1.26B | 1.31B | 1.40B | 1.63B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 38.82M | 30.10M | 31.16M | 28.22M | |
Depreciation
| 32.82M | 28.10M | 29.96M | 27.82M | |
Amortization of Intangibles
| 6.00M | 2.00M | 1.20M | 400.00K | |
COGS Growth
| +10.05% | +4.60% | +6.56% | +16.68% | |
Gross Income
| 531.91M | 581.65M | 624.76M | 799.94M | |
Gross Income Growth
| -1.05% | +9.35% | +7.41% | +28.04% | |
Gross Profit Margin
| +29.76% | +30.69% | +30.86% | +32.88% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 449.12M | 473.30M | 468.62M | 530.50M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 449.12M | 473.30M | 468.62M | 530.50M | |
SGA Growth
| +10.76% | +5.39% | -0.99% | +13.20% | |
Other Operating Expense
| 3.65M | (6.03M) | 5.27M | 1.86M | |
Unusual Expense
| 636.05M | 134.58M | 26.28M | 46.64M | |
EBIT after Unusual Expense
| (556.91M) | (20.20M) | 124.59M | 220.95M | |
Non Operating Income/Expense
| 815.00K | 34.45M | 37.08M | 26.08M | |
Non-Operating Interest Income
| 679.00K | 327.00K | 498.00K | 2.83M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 107.72M | 153.25M | 156.60M | 140.09M | |
Interest Expense Growth
| +56.27% | +42.26% | +2.19% | -10.55% | |
Gross Interest Expense
| 107.72M | 153.25M | 156.60M | 140.09M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (663.81M) | (139.00M) | 5.07M | 106.95M | |
Pretax Income Growth
| -484.47% | +79.06% | +103.65% | +2,008.60% | |
Pretax Margin
| -37.13% | -7.33% | +0.25% | +4.40% | |
Income Tax
| (1.78M) | (4.47M) | 16.00M | (118.09M) | |
Income Tax - Current - Domestic
| (1.67M) | (5.49M) | 14.97M | 24.95M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| (115.00K) | 1.01M | 1.03M | (143.03M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (662.03M) | (134.52M) | (10.93M) | 225.03M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (662.03M) | (134.52M) | (10.93M) | 225.03M | |
Net Income Growth
| -465.63% | +79.68% | +91.88% | +2,159.05% | |
Net Margin Growth
| -37.03% | -7.10% | -0.54% | +9.25% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (662.03M) | (134.52M) | (10.93M) | 225.03M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (662.03M) | (134.52M) | (10.93M) | 225.03M | |
EPS (Basic)
| -3.5679 | -0.7082 | -0.0567 | 1.1057 | |
EPS (Basic) Growth
| -463.12% | +80.15% | +91.99% | +2,050.09% | |
Basic Shares Outstanding
| 185.55M | 189.96M | 192.89M | 203.53M | |
EPS (Diluted)
| -3.5679 | -0.7082 | -0.0567 | 1.0468 | |
EPS (Diluted) Growth
| -463.12% | +80.15% | +91.99% | +1,946.21% | |
Diluted Shares Outstanding
| 185.55M | 189.96M | 192.89M | 214.98M | |
EBITDA
| 117.96M | 144.48M | 182.03M | 295.81M | |
EBITDA Growth
| -29.70% | +22.48% | +25.99% | +62.50% | |
EBITDA Margin
| +6.60% | +7.62% | +8.99% | +12.16% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 10.056 | |
| Number of Ratings | 12 | Current Quarters Estimate | 0.157 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | 0.621 | |
| Last Quarter’s Earnings | 0.126 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.60 | Next Fiscal Year Estimate | 0.691 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 10 | 10 | 11 | 11 |
| Mean Estimate | 0.16 | 0.16 | 0.62 | 0.69 |
| High Estimates | 0.17 | 0.17 | 0.65 | 0.75 |
| Low Estimate | 0.15 | 0.15 | 0.57 | 0.63 |
| Coefficient of Variance | 5.40 | 4.62 | 4.15 | 5.20 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 4 |
| OVERWEIGHT | 1 | 1 | 2 |
| HOLD | 5 | 5 | 5 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Aveanna Healthcare Holdings Inc - AVAH
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Aveanna Healthcare Holdings Inc - AVAH
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 20, 2026 | Edward Reisz Chief Administrative Officer | 1,567,043 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.65 per share | 11,987,878.95 |
| Feb 20, 2026 | Matthew Buckhalter Chief Financial Officer | 529,243 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.21 per share | 3,815,842.03 |
| Feb 20, 2026 | Matthew Buckhalter Chief Financial Officer | 542,755 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.38 per share | 4,005,531.90 |
| Feb 20, 2026 | Matthew Buckhalter Chief Financial Officer | 555,922 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.65 per share | 4,252,803.30 |
| Feb 20, 2026 | Patrick Cunningham Chief Compliance Officer | 337,755 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.21 per share | 2,435,213.55 |
| Feb 20, 2026 | Patrick Cunningham Chief Compliance Officer | 356,191 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.38 per share | 2,628,689.58 |
| Feb 20, 2026 | Patrick Cunningham Chief Compliance Officer | 374,156 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.65 per share | 2,862,293.40 |
| Feb 20, 2026 | Edward Reisz Chief Administrative Officer | 1,447,057 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.21 per share | 10,433,280.97 |
| Feb 20, 2026 | Edward Reisz Chief Administrative Officer | 1,507,826 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.38 per share | 11,127,755.88 |
| Feb 20, 2026 | Deborah Stewart SVP, Chief Accounting Officer | 301,807 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.21 per share | 2,176,028.47 |
| Feb 20, 2026 | Deborah Stewart SVP, Chief Accounting Officer | 312,988 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.38 per share | 2,309,851.44 |
| Feb 20, 2026 | Deborah Stewart SVP, Chief Accounting Officer | 323,884 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.65 per share | 2,477,712.60 |
| Feb 20, 2026 | Rodney D. Windley Director | 2,258,017 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.93 per share | 17,906,074.81 |
| Feb 20, 2026 | Jeffery Shaner Chief Executive Officer | 2,650,892 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.21 per share | 19,112,931.32 |
| Feb 20, 2026 | Jeffery Shaner Chief Executive Officer | 2,824,117 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.38 per share | 20,841,983.46 |
| Feb 20, 2026 | Jeffery Shaner Chief Executive Officer | 2,992,917 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.65 per share | 22,895,815.05 |
| Oct 24, 2025 | J. H. Whitney Capital Partners LLC | 20,544,696 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9 per share | 184,902,264.00 |